What is MNPR stock price today?

Visit our real-time dashboard for the current MNPR stock price and live market data.

Is MNPR stock going up or down today?

MNPR stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.

Should I buy MNPR stock now?

The decision to buy MNPR depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.

Is MNPR a buy, hold, or sell right now?

Our AI-powered analysis provides buy/hold/sell recommendations for MNPR based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.

Is MNPR stock overvalued or undervalued?

Use our DCF valuation calculator to determine if MNPR is overvalued or undervalued based on fundamental analysis and future cash flow projections.

What is MNPR's P/E ratio?

P/E ratio data for MNPR will be available after the company reports earnings. Visit our dashboard for the latest financial metrics.

What is MNPR's market cap?

MNPR (Monopar Therapeutics Inc) has a market capitalization of $0.42 billion, making it a small-cap stock.

What is MNPR's price to book ratio?

Price-to-book ratio for MNPR is available on our dashboard along with other valuation metrics.

Does MNPR pay dividends?

MNPR does not currently pay dividends. Many growth companies reinvest profits into the business rather than paying dividends.

What is MNPR's dividend yield?

MNPR does not currently pay dividends or dividend data is not available. Check our dashboard for the latest information.

Is MNPR stock a good long-term investment?

MNPR's long-term investment potential depends on sustainable competitive advantages, revenue growth, profitability, management quality, and industry dynamics. Our AI analysis evaluates these factors to assess long-term prospects.

What is MNPR's revenue growth rate?

Revenue growth data for MNPR is available on our dashboard with detailed financial statement analysis.

Profitability metrics for MNPR are available on our dashboard with complete income statement analysis.

What are the risks of investing in MNPR?

Key risks for MNPR include market volatility, competitive pressures, regulatory changes, economic conditions, execution risks, and company-specific factors. Our AI analysis identifies material risks and their potential impact on valuation.

How does MNPR compare to its competitors?

Compare MNPR to industry peers on our dashboard using metrics like P/E ratio, revenue growth, profit margins, market share, and valuation multiples. Competitive analysis helps contextualize MNPR's performance and positioning.

What is MNPR's stock price target for 2026?

Visit our prediction page for AI-powered price targets for MNPR with bull, base, and bear case scenarios.

What do analysts say about MNPR?

Wall Street analysts provide ratings (buy/hold/sell) and price targets for MNPR. Our dashboard aggregates analyst consensus, target prices, and recent upgrades/downgrades to help you understand professional sentiment.

When is MNPR's next earnings report?

MNPR reports earnings quarterly. Check our dashboard for the upcoming earnings date, analyst estimates for revenue and EPS, and historical earnings performance. Earnings reports often drive significant stock price movements.

MNPR - Monopar Therapeutics Inc

NYSE * Healthcare * Biotechnology

$0.00

+$0.00 (+0.00%)

About Monopar Therapeutics Inc

Monopar Therapeutics Inc (MNPR) common stock

Price Chart

Loading chart...

MNPR Key Statistics

Market Cap

$422.84M

How MNPR Compares to Peers

MNPR is the smallest among peers, which may offer higher growth potential

P/E Rank

N/A

of 4

Margin Rank

N/A

of 0

Growth Rank

N/A

of 0

Size Rank

of 5

Company	Market Cap	P/E	Growth	Margin	Compare
MNPR(This stock)	$422.84M	N/A	0%	0.0%	-
AMGNAmgen Inc	$163.61B	27.4	0%	0.0%	vs AMGN
GILDGilead Sciences	$160.15B	17.5	0%	0.0%	vs GILD
VRTXVertex Pharmaceuticals	$106.87B	29.7	0%	0.0%	vs VRTX
REGNRegeneron Pharmaceuticals	$59.10B	13.9	0%	0.0%	vs REGN

Data Updated: June 5, 2026 at 11:05 PM EDT

Ready to invest in MNPR?

Commission-free trading available. Affiliate links.

MNPR Lician Score

5% confidence

4.0/10

Neutral

MNPR has a Lician Score of 4/10 (Average). Areas of concern: Growth.

value

5.0

growth

2.0

quality

5.0

momentum

5.0

safety

5.0

The Lician Score is a comprehensive 1-10 rating that evaluates MNPRacross five key dimensions: Value (valuation relative to sector),Growth (revenue and earnings trajectory),Quality (profitability and balance sheet strength),Momentum (price trends and analyst sentiment), andSafety (volatility and risk metrics).

MNPR Financial Snowflake

5-axis analysis across key investment dimensions

4.4/10

Neutral

5.0

Value

Valuation vs. sector peers

2.0

Growth

Revenue & earnings trajectory

5.0

Quality

Profitability & moat strength

5.0

Momentum

Price trends & analyst sentiment

5.0

Safety

Financial stability & risk

Upcoming Events for MNPR

Dashboard

Enter a ticker to analyze